{
  "abstract": "Ewing sarcoma (EWS) is a rare pediatric malignancy of the bone and soft tissue and requires better-tolerated and improved therapies. Oncolytic viruses (OVs) preferentially replicate in cancer cells, causing oncolysis, and activate both innate and adaptive anti-tumor immunity. Thus, OVs have the potential to generate long-lasting, systemic anti-cancer activity. Using a unique panel of patient-derived EWS cultures (PDES), recently derived from patient tumors at diagnosis and relapse, we have identified oncolytic coxsackievirus A21 (CVA21) as a candidate therapeutic OV in EWS, due to its high oncolytic activity and immune stimulation. PDES, unlike established EWS cell lines, expressed intercellular adhesion molecule-1 (ICAM-1), the CVA21 viral entry receptor, and were sensitive to CVA21-mediated oncolysis. Treatment with known ICAM-1 inducers, including tumor necrosis factor (TNF) and the clinically deliverable agent all-trans retinoic acid (ATRA), increased ICAM-1 expression and enhanced CVA21-induced oncolysis. Importantly, while CVA21 replication and oncolysis were inhibited by antiviral type I interferon, pre-treatment with ICAM-1 inducers (or CVA21-induced immune-mediated cytokines) overcame this inhibition. In addition to direct oncolysis, co-culture of CVA21-infected PDES with peripheral blood mononuclear cells (PBMCs) stimulated significant immune-mediated killing. This study presents pre-clinical evaluation of CVA21 using clinically relevant PDES samples and identifies CVA21 as a promising candidate for EWS immunotherapy.",
  "abstract_shown": true,
  "affiliations": [
    "Leeds Institute of Medical Research, University of Leeds, St James’s University Hospital, Wellcome Trust Brenner Building, Beckett Street, Leeds LS9 7TF, UK"
  ],
  "article_type": "research article",
  "arxiv": null,
  "author_total": 8,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Richard T. Baugh"
    },
    {
      "affs": [
        0
      ],
      "name": "Tyler Barr"
    },
    {
      "affs": [
        0
      ],
      "name": "Elizabeth A. Roundhill"
    },
    {
      "affs": [
        0
      ],
      "name": "Fay Ismail"
    },
    {
      "affs": [
        0
      ],
      "name": "Milene Volpato"
    },
    {
      "affs": [
        0
      ],
      "name": "Graham P. Cook"
    },
    {
      "affs": [
        0
      ],
      "name": "Susan A. Burchill"
    },
    {
      "affs": [
        0
      ],
      "name": "Fiona Errington-Mais"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/7znjqt9sr5jwv.bib",
  "cited_by": 0,
  "doi": "10.1016/j.omton.2026.201367",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13755567/",
  "id": "7znjqt9sr5jwv",
  "issns": [
    "2950-3299"
  ],
  "landing_url": "https://doi.org/10.1016/j.omton.2026.201367",
  "language": "en",
  "licence": "CC-BY-4.0",
  "licence_label": "CC BY 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Original Article"
    ],
    [
      "openalex",
      "1311|Virus-based gene therapy research"
    ]
  ],
  "openalex": "W7221791786",
  "pdf_url": null,
  "pmcid": "PMC13755567",
  "pmid": "43022387",
  "published": "2026-10-14",
  "publisher": "American Society of Gene & Cell Therapy",
  "ris": "https://research.draconitic.com/paper/7znjqt9sr5jwv.ris",
  "sources": [
    {
      "first_seen": "2026-11-16T12:21:36Z",
      "native_id": "PMC13755567",
      "source": "pmc",
      "url": "https://doi.org/10.1016/j.omton.2026.201367"
    }
  ],
  "subjects": [
    {
      "field": "biology",
      "origin": "openalex:1311|Virus-based gene therapy research",
      "subfield": "genetics-genomics"
    }
  ],
  "title": "ICAM-1 as a biomarker of efficacy for oncolytic coxsackievirus A21 in patient-derived Ewing sarcoma models",
  "title_text": "ICAM-1 as a biomarker of efficacy for oncolytic coxsackievirus A21 in patient-derived Ewing sarcoma models",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T12:21:36Z",
  "url": "https://research.draconitic.com/paper/7znjqt9sr5jwv",
  "venue": "Molecular Therapy Oncology",
  "versions": []
}